Structure, function, and regulation of adrenergic receptors

Adrenergic receptors for adrenaline and noradrenaline belong to the large multigenic family of receptors coupled to GTP‐binding proteins. Three pharmacologic types have been identified: α1‐, α2‐, and β‐adrenergic receptors. Each of these has three subtypes, characterized by both structural and functional differences. The α2 and β receptors are coupled negatively and positively, respectively, to adenylyl cyclase via Gi or Gs regulatory proteins, and the α1 receptors modulate phospholipase C via the Go protein. Subtype expression is regulated at the level of the gene, the mRNA, and the protein through various transcriptional and postsynthetic mechanisms. Adrenergic receptors constitute, after rhodopsin, one of the best studied models for the other receptors coupled to G proteins that are likely to display similar structural and functional properties.

[1]  A. Strosberg,et al.  The human beta 3-adrenergic receptor is resistant to short term agonist-promoted desensitization. , 1993, Molecular pharmacology.

[2]  R. Lefkowitz,et al.  A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. , 1993, The Journal of biological chemistry.

[3]  B. Mouillac,et al.  Altered phosphorylation and desensitization patterns of a human beta 2‐adrenergic receptor lacking the palmitoylated Cys341. , 1993, The EMBO journal.

[4]  A. Strosberg,et al.  In receptors coupled to GTP-binding proteins, ligand binding and G-protein activation is a multistep dynamic process. , 1993, Drug design and discovery.

[5]  F. Lönnqvist,et al.  Tissue distribution of beta 3-adrenergic receptor mRNA in man. , 1993, The Journal of clinical investigation.

[6]  J. Port,et al.  Cross-talk between tyrosine kinase and G-protein-linked receptors. Phosphorylation of beta 2-adrenergic receptors in response to insulin. , 1992, The Journal of biological chemistry.

[7]  J. Port,et al.  Beta-adrenergic agonists that down-regulate receptor mRNA up-regulate a M(r) 35,000 protein(s) that selectively binds to beta-adrenergic receptor mRNAs. , 1992, The Journal of biological chemistry.

[8]  M. Caron,et al.  Agonist-modulated palmitoylation of beta 2-adrenergic receptor in Sf9 cells. , 1992, The Journal of biological chemistry.

[9]  R. Riek,et al.  Genomic organization and expression of the human alpha 1B-adrenergic receptor. , 1992, The Journal of biological chemistry.

[10]  A. Surprenant,et al.  A point mutation of the alpha 2-adrenoceptor that blocks coupling to potassium but not calcium currents. , 1992, Science.

[11]  A. Strosberg,et al.  Inhibition by dexamethasone of beta 3-adrenergic receptor responsiveness in 3T3-F442A adipocytes. Evidence for a transcriptional mechanism. , 1992, The Journal of biological chemistry.

[12]  M. Caron,et al.  Pharmacological characteristics of alpha 2-adrenergic receptors: comparison of pharmacologically defined subtypes with subtypes identified by molecular cloning. , 1992, Molecular pharmacology.

[13]  G. Barsh,et al.  Cloning of two mouse genes encoding alpha 2-adrenergic receptor subtypes and identification of a single amino acid in the mouse alpha 2-C10 homolog responsible for an interspecies variation in antagonist binding. , 1992, Molecular pharmacology.

[14]  S. Liggett,et al.  Long-term agonist exposure induces upregulation of beta 3-adrenergic receptor expression via multiple cAMP response elements. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[15]  B. Kobilka,et al.  Adrenergic receptors as models for G protein-coupled receptors. , 1992, Annual review of neuroscience.

[16]  D. Bylund.  Subtypes of α1‐ and α2‐adrenergic receptors , 1992 .

[17]  M. Caron,et al.  Discrete amino acid sequences of the alpha 1-adrenergic receptor determine the selectivity of coupling to phosphatidylinositol hydrolysis. , 1992, The Journal of biological chemistry.

[18]  M. Caron,et al.  Mutagenesis of the beta 2-adrenergic receptor: how structure elucidates function. , 1992, Annual review of pharmacology and toxicology.

[19]  A. Strosberg,et al.  Functional expression of receptors in microorganisms. , 1992, Trends in pharmacological sciences.

[20]  M. Caron,et al.  G-protein-coupled receptor genes as protooncogenes: constitutively activating mutation of the alpha 1B-adrenergic receptor enhances mitogenesis and tumorigenicity. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[21]  I. Nishimoto,et al.  Identification of a Gs activator region of the β2-adrenergic receptor that is autoregulated via protein kinase A-dependent phosphorylation , 1991, Cell.

[22]  A. Strosberg,et al.  Atypical beta-adrenergic receptor in 3T3-F442A adipocytes. Pharmacological and molecular relationship with the human beta 3-adrenergic receptor. , 1991, The Journal of biological chemistry.

[23]  M. Berelowitz,et al.  Molecular cloning and sequencing of a cDNA encoding a human α1A adrenergic receptor , 1991 .

[24]  B. Kobilka,et al.  A point mutation in the seventh hydrophobic domain of the alpha 2 adrenergic receptor increases its affinity for a family of beta receptor antagonists. , 1991, The Journal of biological chemistry.

[25]  S. Marullo,et al.  Structural basis for functional diversity of β1-, β2- and β3-adrenergic receptors , 1991 .

[26]  C. Strader,et al.  Allele-specific activation of genetically engineered receptors. , 1991, The Journal of biological chemistry.

[27]  J. Benovic.  Purification and characterization of beta-adrenergic receptor kinase. , 1987, Methods in enzymology.

[28]  William R. Pearson,et al.  Molecular characterization of α1- and α2-adrenoceptors , 1991 .

[29]  A. Strosberg.  Structure/function relationship of proteins belonging to the family of receptors coupled to GTP-binding proteins. , 1991, European journal of biochemistry.

[30]  M. Caron,et al.  Regulation of adrenergic receptor responsiveness through modulation of receptor gene expression. , 1991, Annual review of physiology.

[31]  J. Thorner,et al.  Model systems for the study of seven-transmembrane-segment receptors. , 1991, Annual review of biochemistry.

[32]  M. Caron,et al.  A cAMP response element in the beta 2-adrenergic receptor gene confers transcriptional autoregulation by cAMP. , 1990, The Journal of biological chemistry.

[33]  C. Strader,et al.  Characterization of the binding domain of the beta-adrenergic receptor with the fluorescent antagonist carazolol. Evidence for a buried ligand binding site. , 1990, The Journal of biological chemistry.

[34]  C. A. Guyer,et al.  Cloning, sequencing, and expression of the gene encoding the porcine alpha 2-adrenergic receptor. Allosteric modulation by Na+, H+, and amiloride analogs. , 1990, The Journal of biological chemistry.

[35]  K. Yamamoto,et al.  Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. , 1990, Science.

[36]  Richard Henderson,et al.  A model for the structure of bacteriorhodopsin based on high resolution electron cryomicroscopy , 1990 .

[37]  A. Spiegel.  Receptor-effector coupling by G proteins , 1990 .

[38]  R. Breyer,et al.  Mutational analysis of ligand binding activity of beta 2 adrenergic receptor expressed in Escherichia coli. , 1990, The EMBO journal.

[39]  M. Caron,et al.  Expansion of the alpha 2-adrenergic receptor family: cloning and characterization of a human alpha 2-adrenergic receptor subtype, the gene for which is located on chromosome 2. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[40]  M. Caron,et al.  Involvement of tyrosine residues located in the carboxyl tail of the human beta 2-adrenergic receptor in agonist-induced down-regulation of the receptor. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[41]  M. Caron,et al.  beta-Arrestin: a protein that regulates beta-adrenergic receptor function. , 1990, Science.

[42]  R. Henderson,et al.  Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy. , 1990, Journal of molecular biology.

[43]  M. Caron,et al.  Molecular cloning and expression of the cDNA for a novel alpha 1-adrenergic receptor subtype. , 1990, The Journal of biological chemistry.

[44]  A. Strosberg,et al.  Selective binding of ligands to beta 1, beta 2 or chimeric beta 1/beta 2‐adrenergic receptors involves multiple subsites. , 1990, The EMBO journal.

[45]  M. Caron,et al.  Regions of the alpha 1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[46]  M. Caron,et al.  Role of extracellular disulfide-bonded cysteines in the ligand binding function of the beta 2-adrenergic receptor. , 1990, Biochemistry.

[47]  C. Strader,et al.  A single amino acid substitution in the beta-adrenergic receptor promotes partial agonist activity from antagonists. , 1989, The Journal of biological chemistry.

[48]  M. Caron,et al.  Two distinct pathways for cAMP-mediated down-regulation of the beta 2-adrenergic receptor. Phosphorylation of the receptor and regulation of its mRNA level. , 1989, The Journal of biological chemistry.

[49]  A. Strosberg,et al.  Molecular characterization of the human beta 3-adrenergic receptor. , 1989, Science.

[50]  A. Strosberg,et al.  Expression of Human β1 and β2 Adrenergic Receptors in E. Coli As a New Tool for Ligand Screening , 1989, Bio/Technology.

[51]  C. Malbon,et al.  Agonist regulation of beta-adrenergic receptor mRNA. Analysis in S49 mouse lymphoma mutants. , 1989, The Journal of biological chemistry.

[52]  C. Strader,et al.  Identification of two serine residues involved in agonist activation of the beta-adrenergic receptor. , 1989, The Journal of biological chemistry.

[53]  M. Caron,et al.  Phosphorylation sites on two domains of the beta 2-adrenergic receptor are involved in distinct pathways of receptor desensitization. , 1989, The Journal of biological chemistry.

[54]  M. Caron,et al.  Palmitoylation of the human beta 2-adrenergic receptor. Mutation of Cys341 in the carboxyl tail leads to an uncoupled nonpalmitoylated form of the receptor. , 1989, The Journal of biological chemistry.

[55]  M. Caron,et al.  Inhibition of beta-adrenergic receptor kinase prevents rapid homologous desensitization of beta 2-adrenergic receptors. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[56]  M. Caron,et al.  Structural basis of beta-adrenergic receptor subtype specificity studied with chimeric beta 1/beta 2-adrenergic receptors. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[57]  M. Caron,et al.  Cloning and expression of a human kidney cDNA for an alpha 2-adrenergic receptor subtype. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[58]  J. Venter,et al.  Site-directed mutagenesis of human beta-adrenergic receptors: substitution of aspartic acid-130 by asparagine produces a receptor with high-affinity agonist binding that is uncoupled from adenylate cyclase. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[59]  C. Slaughter,et al.  The catecholamine binding site of the beta-adrenergic receptor is formed by juxtaposed membrane-spanning domains. , 1988, The Journal of biological chemistry.

[60]  M. Caron,et al.  Chimeric alpha 2-,beta 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity. , 1988, Science.

[61]  M. Caron,et al.  Removal of phosphorylation sites from the β2-adrenergic receptor delays onset of agonist-promoted desensitization , 1988, Nature.

[62]  A. Strosberg,et al.  The beta 2-adrenergic receptors of human epidermoid carcinoma cells bear two different types of oligosaccharides which influence expression on the cell surface. , 1988, The Biochemical journal.

[63]  Irving S. Sigal,et al.  Structure-Function Analysis of the β-Adrenergic Receptor , 1988 .

[64]  C. Strader,et al.  Mutations that uncouple the beta-adrenergic receptor from Gs and increase agonist affinity. , 1987, The Journal of biological chemistry.

[65]  E. Ross,et al.  The hydrophobic tryptic core of the beta-adrenergic receptor retains Gs regulatory activity in response to agonists and thiols. , 1987, The Journal of biological chemistry.

[66]  M. Caron,et al.  Cloning of the cDNA for the human beta 1-adrenergic receptor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[67]  C. Strader,et al.  Structural features required for ligand binding to the beta‐adrenergic receptor. , 1987, The EMBO journal.

[68]  M. Caron,et al.  Cloning, sequencing, and expression of the gene coding for the human platelet alpha 2-adrenergic receptor. , 1987, Science.

[69]  A. Strosberg,et al.  Structure of the gene for human beta 2-adrenergic receptor: expression and promoter characterization. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[70]  C. Strader,et al.  The carboxyl terminus of the hamster β-adrenergic receptor expressed in mouse L cells is not required for receptor sequestration , 1987, Cell.

[71]  R. Dixon,et al.  cDNA for the human beta 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[72]  J Ramachandran,et al.  The avian beta-adrenergic receptor: primary structure and membrane topology. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[73]  Brian K. Kobilka,et al.  Cloning of the gene and cDNA for mammalian β-adrenergic receptor and homology with rhodopsin , 1986, Nature.

[74]  A. Strosberg,et al.  The oligosaccharide moiety of the beta 1-adrenergic receptor from turkey erythrocytes has a biantennary, N-acetyllactosamine-containing structure. , 1985, Biochemistry.

[75]  A. Strosberg,et al.  Affinity chromatography of the beta-adrenergic receptor from turkey erythrocytes. , 1979, European journal of biochemistry.

[76]  A. Strosberg,et al.  Evidence for essential disulfide bonds in beta1-adrenergic receptors of turkey erythrocyte membranes. Inactivation by dithiothreitol. , 1979, The Journal of biological chemistry.

[77]  M. Caron,et al.  Affinity chromatography of the beta-adrenergic receptor. , 1979, The Journal of biological chemistry.

[78]  A. Strosberg,et al.  Isolation of adenylate cyclase-free, beta-adrenergic receptor from turkey erythrocyte membranes by affinity chromatography. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[79]  A. M. Lands,et al.  Differentiation of Receptor Systems activated by Sympathomimetic Amines , 1967, Nature.

[80]  R. Ahlquist,et al.  A study of the adrenotropic receptors. , 1948, The American journal of physiology.

[81]  C.,et al.  The Hydrophobic Tryptic Core of the @-Adrenergic Receptor Retains G , Regulatory Activity in Response to Agonists and Thiols * , 2022 .